General Information of DTT (ID: TTWNQ1T)

DTT Name Angiopoietin-1 (ANGPT1) DTT Info
UniProt ID
ANGP1_HUMAN
Gene Name ANGPT1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
3 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
AMG 386 DMQJXL4 Breast cancer 2C60-2C65 Phase 3 [1]
Trebananib DMOG2X1 Ovarian cancer 2C73 Phase 3 [2]
AMG 780 DMTGZN8 Solid tumour/cancer 2A00-2F9Z Phase 1 [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
2 Pediatric Phase I Trial and Pharmacokinetic Study of Trebananib in Relapsed Solid Tumors, Including Primary Tumors of the Central Nervous System ADVL1115: A Children's Oncology Group Phase I Consortium Report. Clin Cancer Res. 2017 Oct 15;23(20):6062-6069.
3 Development and preclinical testing of AMG 780, a fully human antibody targeting angiopoietin 1 (Ang1) and angiopoietin 2 (Ang2). Cancer Research. 10/2014; 74(19 Supplement):1022-1022.